🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

NSPR NSPR

Company Profile ↓
$0.72
-73.03% 1Y
Mkt Cap$31.34M
P/E-0.95
P/B0.57
52W High$2.67
52W Low$0.65
Book Value$1.27
EPS (TTM)$-0.76

Company Overview

NSPR (NSPR) is a publicly traded company listed on with a market capitalization of $31.34M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.06.

Recent Developments

  • Dec 2025 Revenue of $8.98M (+28.1% YoY); net profit $-48.79M.
  • Trailing 12 Months Year-on-year growth — revenue +28.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 6.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:6.67%
1 Year:28.11%

Stock Price Performance

1 Year:-73.03%
6 Months:-56.10%
3 Months:-34.55%
1 Month:+0.00%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 3% of range
$0.65 $2.67
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)51.43 · Neutral
Price Performance
1M+0.00%
3M-34.55%
6M-56.10%
1Y-73.03%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 73.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.95
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.27
Price to Book
0.57
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
6.67%
Profit 5Y
-
Revenue (YoY)
28.11%
Earnings (YoY)
-

Profitability & Returns

ROCE
-84.53%
ROE
-88.38%
ROA
-70.29%
Profit Margin
-
Op Margin
-
Gross Margin
29.50%
EPS (Latest Qtr)
$-0.16
EPS (TTM)
$-0.76

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
5.42
Current Ratio
5.74
Debt
$3.29M
Total Assets
$56.47M
Current Assets
$48.59M
Working Capital
$50.76M

Ownership

Promoter Holding
19.83%
Chg in Prom Hold
0.00%
FII / Inst Holding
49.85%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$8.98M
EBITDA
$-49.14M
Free Cash Flow
$-36.77M
Operating Cash Flow
$-35.10M
Shares Outstanding
43.53M
Gross Margin
29.50%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------640.00K718.00K1.01M1.00M769.00K415.00K1.35M939.00K1.03M313.00K980.00K1.01M1.04M1.07M1.18M1.53M1.43M1.24M1.65M1.56M1.51M1.74M1.81M-1.53M1.78M2.52M3.15M3.40M
Cost of Revenue -----------------------------------1.24M1.47M1.66M1.97M2.71M
Gross Profit 802.00K857.00K-391.00K-76.00K-37.00K-212.00K89.00K66.00K62.00K30.00K74.00K147.00K153.00K293.00K277.00K198.00K-73.00K442.00K128.00K295.00K-120.00K298.00K106.00K262.00K92.00K122.00K431.00K366.00K373.00K491.00K438.00K292.00K331.00K414.00K-292.00K313.00K864.00K1.18M687.00K
Operating Expenses -----------------------------------11.75M13.33M13.91M13.26M14.66M
Operating Income -3.88M-5.54M-7.24M-6.48M-4.89M-3.57M-3.41M-2.03M-1.77M-1.76M-2.40M-2.29M-2.08M-1.95M-1.47M-1.98M-3.13M-2.18M-2.00M-2.02M-2.45M-2.19M-3.31M-3.44M-4.03M-4.49M-4.68M-4.61M-4.38M-5.32M-5.64M-7.41M-8.26M-8.46M--11.46M-13.02M-13.05M-12.08M-13.98M
EBITDA ------------------------------------11.36M-12.91M-12.92M-11.94M-13.83M
Interest Expense ----------------------------------------
Pretax Income ------------------------------------11.17M-13.15M-12.71M-11.70M-13.69M
Tax Provision ----------------------------------------
Net Income -3.94M-5.97M-7.56M-6.78M-5.21M-3.88M-3.64M-2.25M-1.95M-2.00M-2.56M-2.29M-2.09M-2.39M-627.00K-2.01M-3.21M-2.21M-2.07M-1.98M-2.48M-2.23M-3.24M-3.51M-4.07M-4.48M-4.64M-4.53M-4.26M-5.08M-5.18M-7.03M-7.91M-7.89M--11.17M-13.15M-12.71M-11.76M-13.69M
Diluted EPS ---------------------------0.59-0.58-0.53-0.24-0.15-0.21-0.22-0.16--0.22-0.26-0.17-0.14-0.16
R&D Expense 1.54M2.58M2.45M2.46M1.35M747.00K781.00K379.00K278.00K289.00K350.00K403.00K288.00K252.00K230.00K416.00K1.12M865.00K442.00K523.00K444.00K546.00K839.00K1.29M1.50M1.68M2.06M2.06M1.84M1.99M2.11M2.62M3.40M3.92M-4.06M3.83M3.63M-4.76M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Jun 2012Jun 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 3.41M4.95M6.00M5.35M4.87M2.82M2.31M1.89M2.76M3.60M3.72M2.48M-5.17M6.21M7.01M8.98M
Cost of Revenue -------------4.05M4.40M5.50M6.33M
Gross Profit 1.12M2.25M2.99M2.50M2.59M784.00K-296.00K102.00K585.00K995.00K756.00K83.00K-1.12M1.81M1.51M2.65M
Operating Expenses -------------19.83M22.95M35.01M52.26M
Operating Income -2.72M-3.22M-13.73M-17.55M-15.07M-23.70M-14.48M-7.65M-8.23M-7.61M-9.82M-10.38M--18.71M-21.14M-33.50M-49.61M
EBITDA --------------18.52M-20.91M-33.22M-49.14M
Interest Expense ------------157.00K----
Pretax Income --------------18.46M-19.85M-31.95M-48.72M
Tax Provision -------------28.00K65.00K59.00K63.00K
Net Income -2.72M-3.42M-14.66M-17.60M-29.26M-25.09M-15.59M-8.46M-8.44M-7.24M-10.04M-10.54M--18.49M-19.92M-32.01M-48.79M
Diluted EPS --------------2.35-0.82-0.76-0.76
R&D Expense 1.33M1.34M2.47M3.99M4.16M8.74M3.64M1.29M1.28M1.53M2.95M2.23M5.16M7.81M7.98M13.63M15.00M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Jun 2011Dec 2011Jun 2012Jun 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --4.36M-10.46M16.01M20.75M23.97M11.46M5.69M9.41M6.11M12.29M9.88M17.78M39.71M24.65M47.64M46.81M69.40M
Current Assets ----------------21.33M44.16M40.52M61.47M
Cash & Equivalents 1.57M376.00K636.00K8.07M5.09M10.28M14.82M17.54M6.30M3.26M7.52M3.71M9.38M5.51M12.64M12.00M4.63M9.64M18.92M8.94M
Inventory ----------------1.62M2.11M2.57M3.40M
Receivables ----------------1.03M1.80M1.57M2.17M
Total Liabilities --5.27M-3.71M10.63M4.64M15.33M14.25M8.64M5.37M3.11M3.52M4.50M5.61M6.18M7.26M8.14M10.72M14.20M
Current Liabilities --3.94M-3.44M3.55M4.04M6.12M8.47M6.83M4.78M2.48M2.92M3.12M3.71M4.35M5.07M6.02M7.68M10.71M
Long Term Debt --75.00K-----5.09M1.10M----------
Total Debt ----------------1.61M1.59M2.34M3.29M
Total Equity 134.00K-1.34M-914.00K7.16M6.75M5.39M16.10M8.64M-2.79M-2.95M4.04M2.73M8.76M5.38M12.16M33.53M17.39M39.50M36.09M55.20M
Shares Outstanding ----------------8.33M21.84M26.61M43.53M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Jun 2012Jun 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -1.54M-2.71M-6.00M-8.58M-10.30M----8.13M-7.61M-9.81M-9.08M--15.54M-16.38M-21.87M-35.10M
Investing Cash Flow -346.00K-46.00K13.00K-43.00K-376.00K----318.00K-44.00K-387.00K-187.00K-8.44M-16.09M12.64M-30.56M
Financing Cash Flow 655.00K3.04M10.67M11.07M15.12M---4.63M13.37M6.33M16.39M--140.00K37.53M18.45M55.57M
Capital Expenditure -34.00K-81.00K-139.00K-290.00K-202.00K-133.00K-16.00K-49.00K-258.00K-67.00K-284.00K-88.00K--473.00K-381.00K-1.40M-1.66M
Free Cash Flow -1.58M-2.79M-6.14M-8.87M-10.50M----8.39M-7.67M-10.09M-9.17M--16.02M-16.76M-23.27M-36.77M
Net Change in Cash --------------7.24M5.07M9.22M-10.09M
Share Buybacks ---21.00K-------------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Jun 2012Jun 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 32.8%45.5%49.9%46.7%53.2%27.8%-12.8%5.4%21.2%27.6%20.3%3.3%-21.6%29.1%21.5%29.5%
Operating Margin % -79.7%-65.0%-228.7%-328.0%-309.3%-841.0%-627.1%-403.8%-298.2%-211.4%-263.8%-417.7%--361.9%-340.7%-478.0%-552.6%
Net Margin % -79.9%-69.1%-244.3%-329.0%-600.4%-890.5%-674.7%-446.7%-305.6%-201.1%-269.8%-424.3%--357.6%-321.0%-456.6%-543.3%
ROE % 203.4%374.2%-217.1%-326.7%-181.7%900.4%529.0%-209.2%-309.4%-82.6%-186.5%-86.7%--106.3%-50.4%-88.7%-88.4%
ROCE % --783.2%-195.5%-140.8%-90.2%-793.6%1,269.5%-165.1%-227.1%-81.2%-145.1%-73.8%--95.6%-50.8%-85.6%-84.5%

Shareholding Pattern

Insiders
19.83%
Institutions
49.85%
Public Float
62.17%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NSPR

Google News ue, 04 Aug 2026

SpaceX's revenue rises as its once-soaring stock price drifts back to Earth - mynspr.org

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUlo4cFVDZkJpa1hjbkJDT2ZGdVkyOUNvWndMS0lyNTZpM0M1REJOVTd4TjhqeHRYVlA4M1RNMUdKV0ZFOFRpOFFoeHBMRlZ4d0NVVVhmZG1VTS0tM21DeFpsckRNbV9LSDBwYl9nQlFreEd6MktHZXdqV3M3T05PcUo4N0FIZ0otbTZmMD…

Google News hu, 30 Jul 2026

Medical-device sales leader with more than 30 years returns to InspireMD - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNZ1Ryb0l3dXdFY0VWTVltNDB2QU5Xd2pMMGVPVW5VeTNxRUdrT2FRX0dQOUdTRFBwd1BPX1lYd0ZtUm92djNZc25temRNcVFtVWZTYXJYVlpWalNxZ0FxRWVLdU85NVdqTThGeUIwcnYySldFNC1GMmR2TUpvX0wwQno1WUhBaU5sZ3VjeV…

Google News Fri, 31 Jul 2026

InspireMD Inc (NSPR) Institutional Confidence - TradingKey

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5TbWJBajFMSzluU1VLVkU0U3FKWnVadlo0dVVXVkpORWowWHdxR0xraHJqM0Vibm9wX3N2R0lEWERjcDNGSTZuenpSSlFsR21icF8zX0NVd2VHQTBONTJxN2xCdTdZZDQ?oc=5" target="_blank">InspireMD Inc (NSPR) Institu…

Google News Wed, 08 Apr 2026

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQU0N1MVc0VjBnekhzY2l5YTRDTG9NandnVEpCTHRDbXRnZFI2Y2dCN2NUT1hqbjQ5QzQtWlJuQlRnNVhwNlE2VU5lc2xDMmtGTjRueWFtamlWTXRMR1p0WVlxWVhvZF90dE5aNnR2bWExcUJGM2pXRFo1SzlzQjN4LTRwakpYcG41S0hTNU…

Google News Mon, 03 Aug 2026

InspireMD (NSPR) Slides 3.68% to $0.65 as Key Support Holds - Cup and Handle - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNZ1dUaTBHT0RKSEpqTTAwTHpwNmFZX29XekhoTlgxRVFILWlZM3ItY282YkNEcVVuMzNCMVNGWGNQc3hYcUpHWTZBMVpwVTJNTFc4THF1djJIa2VFNXBlM0hLaWxJQ2d0TkZSWUJUQjNyZ241T0J0ODBLVjhtZ0NfaVhzN1U3MWRLcGZvNU…

Google News Sat, 25 Jul 2026

InspireMD Inc. Revenue Breakdown – NASDAQ:NSPR - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9LbFRBUUV4T3JXTUlLNkk5amRGSXRiWTFEenhXTFpzMDZ2WXVTd3VtYVhFeDBWaExaY3JiYW9ETy11NzFmN29QaERhcnBZYnI2VDZYc3Flb2FHNmtUcDhYWk9NTUlUaVFjakduTGpvYnhwZVNOazJn?oc=5" target="_blank">Inspire…

NSPR — Frequently Asked Questions

What is the current share price of NSPR?

As of 2026-08-05 17:25 PDT, NSPR trades at $0.72 on NASDAQ/NYSE. Its 52-week range is $0.65 to $2.67.

What is the market capitalisation of NSPR?

NSPR has a market capitalisation of $31.34M on NASDAQ/NYSE.

What is the P/E ratio of NSPR?

NSPR trades at a trailing price-to-earnings (P/E) ratio of -0.95. Its price-to-book (P/B) ratio is 0.57.

What is the return on equity (ROE) of NSPR?

NSPR has a return on equity (ROE) of -88.38%. Its return on capital employed (ROCE) is -84.53%.

Is NSPR a good stock to buy?

This page provides a data-driven analysis of NSPR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space